COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
David M. Smadja, Steven J. Mentzer, Michaëla Fontenay, Mike A. Laffan, Maximilian Ackermann, Julie Helms, Danny Jonigk, Richard Chocron, Gerald B. Pier, Nicolas Gendron, Stéphanie Pons, Jean‐Luc Diehl, Coert Margadant, Coralie L. Guérin, Elisabeth J. M. Huijbers, Aurélien Philippe, Nicolas Chapuis, Patrycja Nowak‐Sliwinska, Christian Karagiannidis, Olivier Sanchez, Philipp Kümpers, David Skurnik, Anna M. Randi, Arjan W. Griffioen
Topics & Concepts
ARDSAngiogenesisMedicineEndothelial activationImmunologyInflammationVon Willebrand factorEndothelial stem cellVascular endothelial growth factorBasic fibroblast growth factorPathologyLungGrowth factorBiologyCancer researchInternal medicinePlateletVEGF receptorsReceptorBiochemistryIn vitroCOVID-19 Clinical Research StudiesCOVID-19 and healthcare impactsLong-Term Effects of COVID-19